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The zebrafish (Danio rerio) is an excellent animal model for cardiac research [3] [4] [5] because it has a 2-chambered heart that is similar in many genetic ways to the 3-or 4-chambered hearts of higher vertebrates. 6, 7 Embryos of zebrafish are transparent, which makes it possible to observe the dynamic expression of heart genes in a noninvasive manner. They also receive oxygen through diffusion and this type of oxygenation system allows embryos to survive for up to 1 week even with cardiac defects. 8 A 1.6-kb regulatory region of the zebrafish cardiac myosin light chain 2 gene (cmlc2) has been demonstrated to specifically drive green fluorescent protein (GFP) expression in the heart of transgenic zebrafish. 9 We have also generated transgenic lines with myocardium-specific expression of GFP under a tetracycline (Tet)-on conditional expression system. 10 To establish a zebrafish model that is feasible for studying DCM, we designed 2 constructs. One was an upstream plasmid that contained a cmlc2 promoter to specifically drive the expression of a reverse Tet-controlled transactivator (rtTA) in the heart. The other was a downstream plasmid that contained a Tet-binding domain (Tet-O) and possessed a bidirectional promoter to express the GFP reporter and to transcribe cTnCantisense RNA. Antisense knockdown has been widely applied in both in vitro and in vivo studies to block the translation of endogenous mRNA. 11, 12 After gene transfer, a germline-transmitted zebrafish carrying a heart-specific Tet-On system was generated to conditionally produce the antisense RNA of the cTnC gene. Under the impediment of translation of the endogenous cTnC gene, cardiac functional assays were carried out in this transgenic zebrafish after induction. according to the procedures described by Westerfield. 13 The developmental stages were determined according to criteria described by Kimmel et al. 14 
Molecular Cloning of Zebrafish cTnC (Figure 1)
The primers used to clone the cDNA sequence of zebrafish cTnC were designed on the basis of the homologous analysis of cTnC from other known vertebrates. The complete coding region sequence of zebrafish cTnC was amplified by polymerase chain reaction (PCR) using cTnC-SpeI-F (TGACTAGTATGAACGACATCTACAAAGCAGC) and cTnC-PstI-R (TGCTGCAGCTATTCCACCCCTTCATG). The PCR product was used to construct the expression plasmid after it was cut with SpeI and PstI. cTnC polypeptides from various vertebrates were aligned using the BCM Research Launcher and a phylogenetic tree was established from the DNA Data Bank of Japan. The complete coding region sequence was deposited in GenBank (accession number: AF434188, maintained by the NCBI).
Whole-Mount In Situ Hybridization (Figure 2)
In order to determine the tissue-specific expression pattern of the cTnC we cloned, we carried out whole-mount in situ hybridization using a digoxigenin-labeled RNA probe as described previously. 15 Plasmid Construction (Figure 3 ) pICML1-M2 is an upstream plasmid used to produce cardiac-specific rtTA. It was derived from plasmid pICMLE-(-870/787), 9 except that the GFP cDNA was replaced by rtTA-M2. 10 The resulting pICML1-M2 consisted of the regulatory region of cmlc2 (the −870 to -1 region, exon 1, intron 1, and a portion of exon 2), rtTA-M2, and inverted terminal repeats of an adeno-associated virus. Plasmid pBIEK-cTnC-antisense is a downstream plasmid used to produce antisense RNA of cTnC and to express the GFP reporter gene. It was derived from plasmid pBILE, 10 in which SpeI and PstI were used to remove the luciferase gene, which was replaced by ligation with the oppositedirection cTnC cDNA to the rtTA-dependent bidirectional promoter, Tet-O (Clontech).
Gene Transfer
Fertilized eggs at the 1-cell stage were collected and microinjected with linearized constructs of pICML1-M2 and pBIEK-cTnC-antisense, following a previous study except that a total of 15 μg/ml of each plasmid was used. 10 This was the cTnC-antisense group (CA17). Meanwhile, we also microinjected linearized plasmids of pICML1-M2 and pIBIE, 10 in which the cTnC segment was not included, to serve as a control group (T03 group).
Transgenic Line Screening
Embryos were cultured under a 14-h light, 10-h dark photoperiod at 28.5°C. Pairs of mature fish were kept together in tanks. The heart-specific GFP expression in F1 embryos was examined under a fluorescent microscope after induction with 10 μg/ml of Dox (Sigma, St Louis, MO, USA) for 3 days. GFP-positive progeny were selectively bred and mated with wild-type fish when they reached adulthood.
Induction in Embryos
Heterozygotic F2 embryos derived from the transgenic germ lines were kept in water until 12 hours post fertilization (hpf), at which time they were treated with 10 μg/ml of Dox. After induction, GFP expression was observed under a fluorescent microscope. Fish embryos that had heartspecific GFP expression without leakiness were selected, orientated ventrally, and tilted at 45° when taking photos using an S2Pro digital camera (FinePix) with a 10-s exposure time at ISO 400 for image analysis of heart functions. Morphological changes of the heart and heart rate were also examined.
Induction in Adult Fish
The 6-month-old adult fish derived from the cTnC-antisense line (CA17) and the control line (T03) were selected to carry out Dox induction. Ten fish from each group were raised in a tank and treated with 10 μg/ml Dox. In order to prevent Dox from being photodegraded, we covered the tank with tinfoil. The water in the tank was replaced daily. After induction, we observed the fluorescent signal in fish under fluorescent microscopy for 3 weeks.
Extraction of Zebrafish Embryonic mRNA
The heterozygous F2 embryos derived from the transgenic lines CA17 and T03 were treated with Dox (10 μg/ml) when they were at the 12-hpf stage. Another negative control group consisted of those embryos derived from the CA17 transgenic line without Dox treatment. Five embryos at 6 days post fertilization (dpf) from each of these 3 groups were selected, and the mRNA was extracted for further analysis.
Reverse-Transcription (RT)-PCR
In order to detect the endogenous cTnC transcription and the antisense RNA of cTnC transcription after induction, we collected 6-dpf F2 embryos derived from the CA17 and T03 lines. Their total RNA was extracted. All of the RT-PCR procedures followed those of a previous study 16 except that (1) in the first-strand cDNA synthesis we used the Oligo-dT primer to detect the endogenous the cTnC transcription and used TnCA-RT1F primer (CGACATCTACAAAGCAGC-GGCAG; Figure 1C ) to detect the cTnC-antisense strand transcription, and (2) in the following PCR amplification we used primers TnCA-RT2R (GCCAGAACCCTACCCCT-GAAGAGC) and TnCA-RT2F (GTCTCCGTCCCTCAT-CAGTTCCTC) ( Figure 1C ).
Preparation of Monoclonal Antibody for Zebrafish cTnC
Linearized pICML1-M2-BIEK-cTnC-antisense and pICML1-M2-BIEK were injected into cell-stage zebrafish eggs (AB strain) at a concentration of 10 ng/injection and bred in a 28.5°C incubator box. F0, with 2 sets of plasmids injected, were crossed with wild-type. The obtained F1 were induced by Dox (1 g/ml) for 12 h at 2 days of age. The fish were detected by fluorescence expression with a fluorescent microscope. They were then bred until 3 months of age. These F1 fish were induced with Dox (10 g/ml) without light for 1 week. Twenty hearts were obtained and ground with phosphate-buffered saline containing 10 mmol/L PMSF to extract the cardiac protein. The protein concentration was determined via the Bradford protein-binding assay and stored at −20°C for later experimental use. The cDNA sequence of cTnC was obtained from the website for the Zebrafish Information Network. The primer pair was designed as follows: cTnC-fw, (5'-CATATGATGAACGA-CATCTACAAAGCAGC-3'); cTnC-rv, (5'-GGATCCCTA-TTCCACCCCCTTCAT-3'). The zebrafish cardiac cDNA sequence was subjected to PCR and the cTnC sequence was inserted in plasmid pET-15b. The plasmid was then transformed into E. coli (BL21-DE3). Recombinant-cTnC was induced for mass expression in E. coli via IPTG, then purified with recombinant-cTnC using QIAGEN Ni-NTA spin columns. Using recombinant-cTnC as an antigen, mouse monoclonal antibody was prepared by GlycoNex, Inc (Taiwan).
Western-Blot of cTnC in Control and CA17 Groups
The 3-month-old F1 generation (control and CA17 groups) was induced by Dox for 1 week; 2 g of total cardiac protein were loaded on 15% SDS-PAGE for analysis. The extracted protein was transferred to a PolyScreen ® PVDF hybridization transfer membrane. The first antibody (anti-recombinant-cTnC monoclonal antibody, 1:2,000 dilution) was applied at 4°C overnight, then washed with TBST 5 times. The second antibody (anti-mouse AP, 1:5,000 dilution) was applied at room temperature for 2 h, followed by washing with TBST 5 times. Finally, the reaction mixture was developed by NBT/BCIP for analysis. 
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Video File Capture and Processing
The lens adaptor of a stereomicroscope was connected to a digital camera. The LCD monitor of the camera was turned on and connected to the computer with Ulead video studio 7.0 system. The image was captured for 10 s and recorded as an AVI file in the computer. Then the AVI file was converted to bmp files sequentially according to a previously described method, 17 such that 1 bmp file contained 1 frame of cardiac motion. The cardiac motion was viewed frame by frame to define the systolic and diastolic phases. An area with the most-even fluorescent distribution was selected, and the region of the fluorescent heart to be analyzed was marked. The ventricular volume was calculated using the formula for a prolate spheroid: 18 volume = 4/3 ×π× a × b 2 , where a and b are the long and short radii of the ventricle, respectively. The cardiac ejection fraction was calculated by the following formula: (cardiac diastolic volume-cardiac systolic volume)÷cardiac diastolic volume.
Statistical Analysis
All data are expressed as the mean ± standard deviation (SD). Statistical differences among groups were obtained using Student's t-test. It was considered statistically significant at P<0.01.
Results
Primary Structure of Zebrafish cTnC
The complete coding sequence of zebrafish cTnC that we cloned was 486 bp (Figure 1C) , which encoded a 161-amino acid polypeptide ( Figure 1A) . The zebrafish cTnC polypeptide shared 90% identity with those of a mammal, chicken, and Xenopus (Figure 1B) , in which 4 E-F hand calcium-binding domains were highly conserved. On the basis of the phylogenetic tree, the zebrafish cTnC was clustered into the cardiac/slow skeletal muscle group.
Expression of cTnC is Heart-Specific
As shown in the in situ hybridization, the transcripts of the cTnC that we cloned were heart-specific (Figure 2) . The cTnC transcripts were first detectable in 18-hpf embryos, and cTnC was expressed bilaterally in heart precursory cells anterior of the notochord (Figure 2A) . Transcription of the cTnC gene was detected only in the heart-tube of 24-hpf embryos (Figure 2B) , in the whole heart of 48-hpf embryos (Figure 2C) , and in the mature heart of 72-hpf embryos ( Figure 2D ).
Inducible GFP Expression in the Germline-Transmitting Zebrafish
The 12-hpf embryos derived from F1 of the transgenic cTnC-antisense line (CA17) and the transgenic control line T03 were collected and treated with 10 μg/ml Dox. The CA17 line expressed both the GFP and the antisense mRNA of cTnC, whereas the T03 line expressed the GFP only. Without Dox treatment, there was no green fluorescent signal in the fish. However, after induction, the green fluorescent signal began to appear specifically in the heart about 12 h after treatment ( Figure 4A ).
Transcription of cTnC Antisense RNA in Transgenic Fish
As shown in Figure 4B , cTnC mRNA was produced by the transgenic lines of both CA17 and T03 after induction by Dox; whereas the antisense RNA transcribed from the cTnC gene was clearly shown in embryos derived from CA17 transgenic fish after Dox induction. Although a very weak signal of antisense RNA was shown prior to induction, the green fluorescent signal was not detected. In contrast, the antisense RNA of cTnC was not produced in embryos derived from the control transgenic line T03. As long as cTnC antisense RNA was expressed in CA17 embryos, the expression of endogenous cTnC mRNA remained the same.
Western Blot of cTnC in Control and CA17 Groups
Expression of recombinant protein cTnC was performed in E. coli (BL21-DE3) as antigen for monoclonal antibody preparation. The size of cTnC was approximately 22 kD; arrow in Figure 5A ). The results of cardiac protein extraction by SDS-PAGE were analyzed and used for monoclonal antibody preparation. Western blot of cTnC by monoclonal antibody showed that the expression of cTnC decreased Heart Rates of CA17 and T03 Transgenic Zebrafish at 6 and 12 dpf At 3 dpf, heart rates of the CA17 group were slightly faster than those of the T03 group. With further growth, the situation gradually reversed. The heart rates of the CA17 were significantly slower than those of the T03 at 6 (150±10 vs 194±11 beats/min, P<0.01) and 12 dpf (128±12 vs 168± 8 beats/min, P<0.01).
Ventricular Assessments of CA17 and T03 Zebrafish at 6 and 12 dpf
End-diastolic and end-systolic diameters significantly differed between the control line (T03) and the cTnC-antisense line (CA17) groups at both 6 and 12 dpf (Tables 1,2) . The ventricular ejection fraction of the CA17 was lower than that of the T03 transgenic fish (44±4% vs 52±3%; P<0.01). At 12 dpf, the ventricular ejection fraction of the CA17 was even lower than that of the T03 (39±5% vs 52±4%; P<0.01).
Measurements from the hearts of the T03 transgenic fish were calculated to obtain the arithmetic mean and standard deviation. The range of mean ± 2SDs was defined as normal. Percentages of the upper outlier for the cardiac chambers and lower outlier for the ejection fraction and heart rates in the CA17 group are presented in Table 3 . Figure 4 . Detection of the expression of GFP and the transcription of the antisense RNA of cTnC. The 12-hpf embryos derived from the cTnC-antisense transgenic line, CA17, were collected and incubated in 10 μg/ml Dox. Green fluorescence was observed in the heart at 48 hpf (A). The reverse-transcription polymerase chain reaction was used to detect the transcription of endogenous cTnC mRNA and the transcription of cTnC antisense RNA (B). Embryos were treated with Dox after 12 hpf, and the total RNA was extracted when these embryos reached 6 dpf. Antisense cTnC was strongly detected in the CA17 group after induction. Although the antisense RNA of the cTnC gene was slightly detected in the non-induced group, the green fluorescent signal was not detected. Expression of the endogenous cTnC gene was almost the same in the T03 and CA17 groups, which suggests that the antisense of cTnC did not interfere in the expression of the endogenous cTnC gene. Arrow indicates the position of the heart. See Figures 1-3 for abbreviations. dpf, days post fertilization; hpf, hours post fertilization; T03, control transgenic line that expressed the green fluorescence protein (GFP) reporter after induction; CA17, transgenic line that expressed the GFP reporter and transcribed the antisense RNA of the cardiac troponin C (cTnC) gene after induction; EF, ejection fraction.
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Atrial and Ventricular Asynchrony in CA17 Zebrafish At 6 dpf, atrial and ventricular contractions were synchronized in F2 embryos from the cTnC-antisense line, CA17, after induction. However, 1.3% of F2 embryos from the CA17 transgenic fish developed asynchronized atrial and ventricular contractions at 12 dpf.
Slurred Movement and Excess Mortality in cTnC-Antisense Transgenic Adult Fish After Dox Induction
After Dox had been continuously administered to 6-monthold fish derived from homozygous parents, we found that the movement of fish from the CA17 group was slower than that of the T03 group. Furthermore, 30% (3/10) of fish from the CA17 group had died by day 13, whereas no mortality had occurred in the T03 group.
Discussion
Functional abnormalities of cardiac troponin caused by either mutations or auto-antibodies have been reported to induce DCM. 2, 19 Cardiac troponin T variants produced by aberrant splicing of multiple exons in animals have been related to high rates of DCM. 20 However, there has not been a report of a transgenic animal model for cTnC dysfunction. On the other hand, cTnC plays an important role in the cardiac excitation-contraction coupling process and is also the target protein of the calcium sensitizers (levosimendan and pimobendan). 21 Calcium sensitizers have high therapeutic potential for the treatment of contractile dysfunction in congestive heart failure, because they have energetic advantages and less risk of Ca 2+ overload. 21 Therefore, the role of cTnC dysfunction in heart failure is worth studying.
By fusing the Tet repressor and activating the transcription domain of virion protein 16 of the herpes simplex virus, the Tet-controlled transactivator (tTA) is generated. 22 A Tet-On system is further developed by mutagenesis, substituting 4 amino acids in tTA to generate rtTA, which requires Tet for binding to the Tet operon and subsequent activation of the downstream gene. 23 For pharmacokinetic reasons, controlling genes by means of rtTA is particularly advantageous in the study of transgenic animals. We have successfully developed such a Tet-On system in zebrafish, which enables the transgene to be specifically expressed in the heart after induction. 10 This technique also makes it feasible for later onset of abnormal gene expression in adult transgenic fish. Therefore, this methodology extends the utilization of zebrafish as a model organism from congenital cardiac disorders to acquired heart diseases.
In the present study, cTnC antisense mRNA was noted only in fish from the cTnC-antisense transgenic line, CA17, induced by Dox. The fish from the control transgenic line, T03, could not produce cTnC antisense mRNA. The ventricular size and the prevalence of ventricular enlargement increased significantly in the CA17 group at 6 and 12 dpf. The ventricular ejection fraction of the CA17 group was also significantly lower than that of the T03 group at 6 and 12 dpf. On the other hand, relative bradycardia was noted despite the impaired contractility in the CA17 group. Chronotropic incompetence was another major finding in the cTnC antisense zebrafish. Even 1.3% of CA17 transgenic fish manifested asynchronized atrial and ventricular contractions. Atrioventricular conduction block can lead to sudden death, which has been reported for troponin-related DCM in humans. 2 According to Sedmera et al, trabecular bands form direct myocardial continuity between the atrio- ventricular canal and the apex of the ventricle in zebrafish 24 and cTnC may play a role in these bands. It is interesting to observe the activities of adult fish derived from the homozygotes of the CA17 transgenic line after continuous treatment with Dox. The movement of cardiomyopathy-induced fish was slower, and 30% of them died early, whereas fish from the T03 control group lived normally. It seemed that the low cardiac output failed to supply adequate perfusion to skeletal muscles, resulting in a slurring of body movements. The high mortality of fish from the CA17 line after induction may have been caused either by a power failure or a conduction abnormality of the hearts. These phenomena are frequently observed in human patients with heart failure.
The zebrafish heart contains 4 components (sinus venosus, atrium, ventricle, and bulbus arteriosus). Although it has a prototypic vertebrate heart, the zebrafish has been used to study bradycardia, formation of cardiac valves and cardiac regeneration. 3, 4, [25] [26] [27] [28] [29] There are many heart failure models using mice and rat. 30, 31 However, the amino acid sequences of cTnC are highly conserved from fish to mammals. The overall identity is 90%, not only in the 4 calcium-binding domains but also in the entire fragment. The possibility of extending this model to mice or rats is high and there are several applications of this model to clinical science. First, it offers a phenotype for comparison with that of human DCM caused by cTnC mutation. Second, it is a useful model for studying the cardiac excitation-contraction coupling process. 21 Third, this model has potential as a drug-screening assay for calcium sensitizers.
In conclusion, the cTnC antisense zebrafish developed in this study offers a new investigative tool for human heart failure.
